A Clinical Study of Iparomlimab and Tuvonralimab Combined With Bevacizumab and Alternating Triweekly CAPOX/mCAPIRI Regimen as First-line Treatment for Unresectable Advanced Colorectal Cancer
PHASE2
This study is a prospective, single-arm, multicenter exploratory clinical s...
Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer
PHASE3
The aim of this clinical trial is to compare triplet induction therapy (FOL...
Efficacy and Toxicity of Total Neoadjuvant Sandwich Treatment Via Short Course Radiotherapy in the Treatment of Stage II and III Rectal Cancer Patients
PHASE2
Several trials showed that total neoadjuvant treatment (TNT) in stage II/II...
Status
Recruiting
Location
Clinical oncology and nuclear medicine Department, Faculty of medicine, Ain Shams University
Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015)
PHASE3
The purpose of this study is to assess the efficacy and safety of lenvatini...
Status
Completed
Location
UCLA Hematology/Oncology - Santa Monica ( Site 0003)